Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial
Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe study page now displays a server error page with a basic HTML frame. This replaces the full study record and related content on the page.SummaryDifference20%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision tag was updated from v3.6.3 to v3.6.4, signaling a small backend/content update with no visible changes to the study details shown to users.SummaryDifference0.0%

- Check51 days agoChange DetectedPage build updated from v3.6.2 to v3.6.3. This reflects a new release of the page rather than content changes.SummaryDifference0.0%

- Check59 days agoChange DetectedThe page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page’s software. This update likely represents minor fixes or improvements behind the scenes rather than user-facing content changes.SummaryDifference0.0%

- Check73 days agoChange DetectedThe page was updated to show that recruitment is closed. It also adds user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment heading, while updating the revision banner to v3.6.0.SummaryDifference0.3%

- Check80 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5. This reflects an updated page revision in the site's versioning system rather than a change to study data or content.SummaryDifference0.0%

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.